Forxiga: new “flozin” for type 2 diabetesSecond SGLT2 inhibitor reaches Canadian market. Diabetes: Tight control extends life Drug helps preserve beta-cell function in type 2 diabetes But beneficial effect is lost once medication is stopped Hypoglycemia: Emergency care varies Study suggests need for guidelines and improved discharge planning Ask the Diabetes Expert: Metformin What’s your opinion on metformin given to diabetic patient with eGFR lower than 50ml/min? First-trimester test predicts diabetes in pregnancy Study suggests targeted prevention of gestational diabetes is possible Type 1 diabetes: Learning from the long-haulers Retinopathy is the surprise number-one complication decades after diagnosis Gout linked with increased diabetes risk Study supports proper recognition and management of risk factors, researchers say Ease up on A1C in diabetes patients with heart disease But overall risk factor management needs improvement, national study finds Cardiometabolic age: A new way to motivate patients Model estimates lifetime risk of diabetes and cardiovascular complications First Previous 37 38 39 40 41 Next Last
